Protecting Editorial Integrity – Dr. Stefan Kreuszewski BMJ Sun, 6 Feb 2005 In his BMJ editorial, “A tough nut to crack,” Kamran Abassi writes: “The drug industry considers the BMJ a tough nut to crack,” an insider recently told us. Publishing a “favourable” research paper is far trickier in the…
What the FDA Isn’t Telling You – SLATE Date: Tue, 27 Sep 2005 Writing in SLATE, Jeanne Lenzer has uncovered evidence demonstrating FDA culpability in helping drug manufacturers conceal vital, life-saving information from the public. In this case, undisclosed suicides in clinical trials testing Eli Lilly’s drug, duloxetine (trade names:…
FDA Tones Down Warning–Shyra Kallas an SSRI Suicide Victim Fri, 4 Mar 2005 In his recent testimony before the Senate Health, Education, Labor, and Pensions committee, Dr. David Fassler, representing the American Psychiatric Association (APA) and the American Academy of Child and Adolescent Psychiatry (AACAP), misrepresented the scientific facts about…
NIH: Public Servant or Private Marketer? NIH Seeks Outside Inquiry of Alzheimer’s researcher conflicts of interest – LAT Mon, 31 Jan 2005 A year after the Los Angeles Times published its first an in-depth investigative report documenting in detail evidence of major conflicts of interest by top scientists at the…
Pfizer Admits Guilt in Promotion of Neurontin–Agrees to Pay $430 Million Sun, 16 May 2004 A lawsuit initiated by Dr. David Franklin, a whistleblower, has been settled: Pfizer pleaded guilty to criminal fraud in the promotion of Neurontin, and agreed to pay $430 million. This case is but an example…
Just Say No – Forbes Tue, 16 Nov 2004 When Mrs. Nancy Reagan coined the phrase, Just Say No, she was referring to illicit drug pushers. The current Forbes cover story–Just Say No–refers to the prescription drug industry. "In a perverse kind of symbiosis, the cascade of disease and medical…
Bush Plans to Screen Whole US Population for Mental Illness – BMJ Thu, 24 Jun 2004 A second article in the British Medical Journal discloses additional evidence uncovered by Allen Jones, the whistle blower from the Pennsylvania Inspector General’s Office. The first BMJ article focused on the Texas Medication Algorithm…
Screening for Mental Illness–A Diabolical, Profit-Enhancing Experiment Fri, 22 Oct 2004 Concerned citizen groups are joining our effort to stop the government from implementing a sweeping recommendation for lifetime screening for mental illness. If implemented, the first to be screened for hidden mental illness are America’s 52 million school children…
Wyeth Pharma Warns Doctors Against Rx Effexor to Kids Tue, 2 Sep 2003 View Wyeth Warning Letter The Hartford Courant reports that the latest warning against prescribing an antidepressant drug for children comes from Wyeth Pharmaceuticals, makers of Effexor, a drug just like Prozac, Zoloft, and Paxil–a class known as…
THE IMPACT OF THE FDA MODERNIZATION ACT ON THE RECRUITMENT OF CHILDREN FOR RESEARCH Vera Hassner Sharav Published in ETHICAL HUMAN SCIENCES & SERVICES Summer 2003, vol. 5 pp. 83-108 Abstract This paper argues that contrary to the claims made by the research stakeholders in industry, academia and government, the…
Marketing Diseas – NYT /APA invites Soprano-Actress Psychiatrist– Pfizer Spokeswoman to speak at conference Fri, 13 May 2005 The New York times reported how drug companies invent and market a disease in order to ensure a market for newly developed drugs. Under the influence of the pharmaceutical industry, illness does…
Pfizer Statements RE: Bextra, Celebrex, Neurontin Shown to be Lies Fri, 08 Apr 2005 The New York Times reports that “as recently as Tuesday [Pfizer] assured Wall Street that sales of Celebrex and Bextra would soon rebound. It was the latest in a string of announcements by the company regarding…
